TrianglePUBLICATIONS · 35690073
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2022 Jul
- First author
- Clamp AR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Clamp AR
- type
- Author
- name
- James EC
- type
- Author
- name
- McNeish IA
- type
- Author
- name
- Dean A
- type
- Author
- name
- Kim JW
- type
- Author
- name
- O'Donnell DM
- type
- Author
- name
- Gallardo-Rincon D
- type
- Author
- name
- Blagden S
- type
- Author
- name
- Brenton J
- type
- Author
- name
- Perren TJ
- type
- Author
- name
- Sundar S
- type
- Author
- name
- Lord R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Clamp AR
- type
- Author
- name
- James EC
- type
- Author
- name
- McNeish IA
- type
- Author
- name
- Dean A
- type
- Author
- name
- Kim JW
- type
- Author
- name
- O'Donnell DM
- type
- Author
- name
- Gallardo-Rincon D
- type
- Author
- name
- Blagden S
- type
- Author
- name
- Brenton J
- type
- Author
- name
- Perren TJ
- type
- Author
- name
- Sundar S
- type
- Author
- name
- Lord R
- type
- Author
- bibliography ids
- nci-bib-7c154cf04cf3a8dfb3031c08
- book metadata
- content sha256
- 99ddb674a55b3e2ac9c29b6f3cada82e0b62cfa04612e89758b71ddb6e137cdc
- document type
- citation
- dois
- 10.1016/S1470-2045(22)00283-2
- electronic publication date
- display
- 2022 Jun 9
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35690073
- immutable id
- pubmed:35690073@99ddb674a55b3e2ac9c29b6f3cada82e0b62cfa04612e89758b71ddb6e137cdc
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 7
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 919-930
- volume
- 23
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35690073
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- 11006d6ca527fcbe0f5f31996584f29d7c7764dbb2c8d94835e3874f323b1cbb
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2022 Jul
- precision
- month
- year
- 2022
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Preserved source evidence · Not medical advice